Shots:

• RetinAI signs a multi-year collaboration with Novartis under which RetinAI’s IT solutions and AI tools will be employed to support multiple projects in ophthalmology and digital health
• The first project under the agreement will support a multi-center international clinical study involving patients with nAMD. The study is designed to investigate the influence of OCT image solutions using AI on the assessment of disease activity
• The study will be conducted across multiple centers in numerous EU countries and Canada- involving 500+ patients. RetinaAI will provide its data management platform to efficiently process data at scale across imaging platforms and devices

 ­ Ref: RetinAI | Image: Novartis